ST
Neuronetics, Inc.
STIM · NASDAQ
$3.03 -2.26% (-$0.07)
1M -8.18%
Market Cap $209.5M
P/E Ratio -
Div. Yield -
ROE 150.56%
Bulios Fair Price
$1.86
38.6% downside
Current Price
$3.03
Undervalued Fair Value Overvalued
According to Bulios Fair Price, STIM is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
48 /100
Fair P/B 11.73x
P/S 1.35x
EV/FFO N/A
Growth
78 /100
Growing Book val. growth 26.80%
Rev. growth 31.76%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 14.74%
Gross margin 49.12%
FCF margin 6.50%
Quality
15 /100
Poor ROA 23.14%
ROIC 21.10%
Asset turnover 1.18x
Debt
22 /100
High Int. coverage -2.67x
Debt/Equity 4.85x
Current ratio 1.88x
Stability
31 /100
Unstable EPS volatility 44.79%
Beta 1.17x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STIM
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Daniel L. Reuvers
Employees
658
Headquarters
Malvern
Upcoming events
03 NOV
Earnings
Upcoming earnings report